IPIX (Innovation Pharmaceuticals) Research & Development: $0.87 Mil (TTM As of Sep. 2023)


What is Innovation Pharmaceuticals Research & Development?

Innovation Pharmaceuticals IPIX Research & Development is $0.87 Mil as of Sep. 2023.

Research & Development is the aggregate amount of research and development expenses during the year. Innovation Pharmaceuticals's Research & Development for the three months ended in Sep. 2023 was $0.28 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 was $0.87 Mil.

Innovation Pharmaceuticals  (OTCPK:IPIX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Innovation Pharmaceuticals Research & Development Related Terms

Innovation Pharmaceuticals Research & Development Historical Data

* Premium members only.

The historical data trend for Innovation Pharmaceuticals's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation Pharmaceuticals Research & Development Chart

Innovation Pharmaceuticals Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.34 2.79 7.02 4.81 1.46

Innovation Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 -0.03 0.32 0.30 0.28

Innovation Pharmaceuticals Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.87 Mil mean?
Innovation Pharmaceuticals (IPIX) has a Research & Development of $0.87 Mil as of Sep. 2023. Research and development expense is the total cost for research and development activities. View historical data on Innovation Pharmaceuticals and its competitors.
Is Innovation Pharmaceuticals' Research & Development too high?
Innovation Pharmaceuticals' current Research & Development is $0.87 Mil.
How does Innovation Pharmaceuticals' Research & Development compare to AXIM and RNAZ?
Innovation Pharmaceuticals' Research & Development of $0.87 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Innovation Pharmaceuticals and its competitors. Innovation Pharmaceuticals's current Research & Development is $0.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation Pharmaceuticals stock overvalued right now?
Innovation Pharmaceuticals (IPIX) has a current Research & Development of $0.87 Mil. The current Research & Development is $0.87 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Innovation Pharmaceuticals (IPIX), the current Research & Development is $0.87 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation Pharmaceuticals Business Description

Address 301 Edgewater Place, Suite 100, Wakefield, MA, USA, 01880
Innovation Pharmaceuticals Inc is a clinical-stage pharmaceutical company in the United States. It is engaged in developing therapies with oncology, dermatology, and antimicrobial applications. Its clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Brilacidin, a potential therapeutic for the treatment of the novel coronavirus. The company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics, and inflammatory disease.